Shuangshuang Fu
Overview
Explore the profile of Shuangshuang Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiao Z, Li G, Fu S, Chen Y
FASEB J
. 2024 Dec;
38(24):e70253.
PMID: 39680018
Tubulointerstitial injury has been increasingly recognized as an important component in lupus nephritis (LN) pathology over the last decades. However, current clinical treatment options for this process remain limited. In...
2.
Liu M, Long X, Fu S, Zhang Y, Liu Z, Xu X, et al.
J Transl Autoimmun
. 2024 Oct;
9:100251.
PMID: 39434801
Background: Mitochondrial DNA plays a crucial role in the pathophysiology of autoimmune diseases (ADs). However, the association between mitochondrial DNA copy number (mtDNA-CN) and ADs risk is controversial. In this...
3.
Zhang F, Yu J, Li G, Fu S, Xiao H, Yang Y, et al.
Hemodial Int
. 2024 Mar;
28(2):170-177.
PMID: 38448796
Introduction: Arteriovenous fistula (AVF) dysfunction is a prevalent complication among maintenance hemodialysis patients. However, the factors influencing AVF patency remain unclear. To address this, we conducted a study aimed at...
4.
Wang Y, Wu A, Xu Z, Zhang H, Li H, Fu S, et al.
Int Immunopharmacol
. 2023 Dec;
127:111351.
PMID: 38113688
Brucellosis, a zoonosis caused by Brucella, is highly detrimental to both humans and animals. Most existing vaccines are live attenuated vaccines with safety flaws for people and animals. Therefore, it...
5.
Zhang F, Li G, Yu J, Shen Y, Yang Y, Fu S, et al.
Blood Purif
. 2023 Nov;
53(4):288-300.
PMID: 37972579
Introduction: This study aimed to evaluate the characteristics and prognostic factors for coronavirus disease 2019 (COVID-19) patients on maintenance hemodialysis (HD). Methods: All admitted HD patients who were infected with...
6.
Hoffman A, Denham C, Fu S, Mendoza T, Nitecki R, Jorgensen K, et al.
Int J Gynecol Cancer
. 2023 Mar;
33(5):778-785.
PMID: 37001892
Objective: With a growing population of young cancer survivors, there is an increasing need to address the gaps in evidence regarding cancer survivors' obstetric outcomes, fertility care access, and experiences....
7.
Vranes C, Zhao H, Noer M, Fu S, Sun C, Harrison R, et al.
Int J Gynecol Cancer
. 2023 Mar;
33(5):749-754.
PMID: 36863760
Objectives: The Ovarian Cancer Comorbidity Index (OCCI) is an age-specific index developed and previously found to be more predictive of overall and cancer-specific survival than the Charlson Comorbidity Index (CCI)....
8.
Jorgensen K, Nitecki R, Nichols H, Fu S, Wu C, Melamed A, et al.
Obstet Gynecol
. 2022 Nov;
140(6):939-949.
PMID: 36357983
Objective: To evaluate obstetric and neonatal outcomes of the first live birth conceived 1 or more years after breast cancer diagnosis. Methods: We performed a population-based study to compare live...
9.
Huepenbecker S, Fu S, Sun C, Zhao H, Primm K, Giordano S, et al.
Ann Surg Oncol
. 2022 Oct;
30(3):1508-1519.
PMID: 36310311
Background: The association between Medicaid expansion and postoperative mortality after surgery for gynecologic cancer is unknown. Our objective was to compare 30- and 90-day postoperative mortality after gynecologic cancer surgery...
10.
Huepenbecker S, Sun C, Fu S, Zhao H, Primm K, Rauh-Hain J, et al.
Int J Gynecol Cancer
. 2022 Sep;
32(9):1153-1163.
PMID: 36166208
Objective: Evaluate the association between time to diagnosis and treatment of advanced ovarian cancer with overall and ovarian cancer specific mortality using a retrospective cross sectional study of a population...